Autolus Therapeutics Q3 EPS $(0.21) Misses $(0.18) Estimate, Sales $41.238M Beat $39.537M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 30 percent increase over losses of $(0.30) per share
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 30 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $41.238 million which beat the analyst consensus estimate of $39.537 million by 4.30 percent. This is a 94.57 percent increase over sales of $21.194 million the same period last year.